Clinical Trials Logo

High Bleeding Risk Patients clinical trials

View clinical trials related to High Bleeding Risk Patients.

Filter by:
  • None
  • Page 1

NCT ID: NCT05643430 Recruiting - Clinical trials for Coronary Artery Disease

ULTRA LONG: BioFreedom Ultra

Start date: February 27, 2024
Phase: N/A
Study type: Interventional

The goal of this Prospective, multi-center, open-label single-arm study is to Assess the Safety and Effectiveness of additional sizes of the BioFreedom Ultra CoCr Biolimus A9 coated coronary stent system in Patients at high risk of bleeding (HBR). The main question it aims to answer is to evaluate if the additional sizes of the BioFreedom Ultra have corresponding clinical safety and efficacy characteristics as the regulatory approved (=CE Marked) sizes.

NCT ID: NCT01930903 Active, not recruiting - Clinical trials for Coronary Artery Disease

PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon

PaneLux PTCA
Start date: September 2013
Phase: N/A
Study type: Interventional

The propose of this study is to demonstrate, whenever using Drug Eluting Stent is not possible, the clinical security at 12 months, of the combinaison Bare Metal Stent plus Drug Eluting Balloon.